Independent reference. Not affiliated with, endorsed by, or speaking for the U.S. Food and Drug Administration.

Baxfendy (baxdrostat)

The FDA approved Baxfendy (baxdrostat) on May 15, 2026 to treat hypertension in combination with other antihypertensive drugs.

Brand name: Baxfendy
Generic name: baxdrostat
FDA approval date: May 15, 2026
Approved use (FDA wording): To treat hypertension in combination with other antihypertensive drugs
Category on this site: Heart & blood

Official sources

FDA novel drug approvals list

Facts only. This site lists what the FDA has approved and what the FDA says each drug is approved for, quoted or closely paraphrased from FDA and openFDA records. It gives no medical advice, no dosing, and no comparisons, and it says nothing about whether a drug is right for anyone. Talk to a licensed clinician about any medication. Records can lag or contain errors; the FDA's own pages are authoritative.